The global PCR technologies market is projected to reach USD 9.8 billion by 2025 from USD 7.2 billion in 2020, at a CAGR of 6.3% from 2020 to 2025.
The rising incidence of infectious diseases and genetic disorders across the world has spurred the demand for better and faster diagnostic tests. This has also boosted the overall pace of R&D in the PCR technologies market along with the availability of strong financial support in the form of investments, funds, and grants. These factors are driving the growth of PCR technologies market during the forecast period. However, high instrument costs - especially that of dPCR - and the technical limitations of PCR are expected to limit market growth to a certain extent.
The qPCR segment is expected to account for the largest market share of the global PCR technologies market in 2020
The qPCR segment is expected to account for the largest share among PCR techniques in 2020. The expanding applications of qPCR (owing to its technological benefits over traditional PCR, such as real-time analysis and reduced analysis time), growing private-public funding for life sciences research, and the rising number of probe-based multiplex genetic analysis procedures (that require the analysis of low-volume gene samples) are expected to drive the growth of the qPCR market.
Reagents and consumables segment to show the highest growth in the PCR technologies market during the forecast period
The reagents and consumables segment will show the highest growth in the PCR technologies market during the forecast period. The growth of this segment can be attributed to factors such as the expanding applications of dPCR, the increasing number of dPCR-based analytical procedures among institutional researchers (such as CROs and pharma-biotech companies), and the rising availability of novel dPCR reagents worldwide. Additionally, the expansion of the application base of the dPCR technology in genetic/molecular research, clinical diagnosis, and forensics is expected to result in the commercialization of novel dPCR reagents.
North America to account for the largest share of the global market in 2020
North America accounts for the largest share of the PCR technologies market owing to the high incidence of chronic and genetic diseases, rising geriatric population, growing adoption of PCR techniques in research & academia, and significant public-private funding in the field of genome analysis. Further, the strong presence of major pharmaceutical and biotechnology companies in the US and ongoing initiatives by the Canadian government to support life science, genomic, and clinical research are other few factors influencing the demand for PCR products in this region.
Research Coverage
This report studies the PCR technologies market based on product and services, application, end user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions and the respective countries in these regions.
The major players in the market include Abbott Laboratories (US), Agilent Technologies, Inc. (US), Analytik Jena AG (Germany), Becton Dickinson and Company (US), bioMérieux S.A. (France), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Eppendorf AG (Germany), F. Hoffman-La Roche Ltd. (Switzerland), Fluidigm Corporation (US), Merck KGaA (Germany), Promega Corporation (US), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), and Thermo Fisher Scientific, Inc. (US).
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1: 48%, Tier 2: 36%, and Tier 3: 16%
- By Designation: C-level 10%, D-level: 14%, and Others: 76%
- By Region: North America: 40%, Europe: 32%, APAC: 20%, Latin America: 5%, and the Middle East & Africa: 3%
Key Benefits of Buying the Report
This report focuses on various levels of analysis - industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the market, and high-growth regions, as well as their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Market Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.2 Market Estimation Methodology
2.2.1 Revenue Mapping-Based Market Estimation
2.2.2 Usage-Based Market Estimation
2.2.3 Primary Research Validation
2.3 Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations
3 Executive Summary
4 Premium Insights
4.1 PCR Technologies Market Overview
4.2 PCR Technologies Market Share, by Technique, 2020 Vs. 2025
4.3 PCR Technologies Market, by Application, 2020 Vs. 2025 (USD Million)
4.4 PCR Technologies Market, by Region, 2020-2025
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Rising Incidence of Target Infectious Diseases and Genetic Disorders
5.2.1.2 Continuous Advancements in PCR Technologies
5.2.1.3 Increasing Investments, Funds, and Grants
5.2.1.4 Increasing Use of Biomarker Profiling for Disease Diagnostics
5.2.1.5 Successful Completion of the Human Genome Project
5.2.2 Key Market Restraints
5.2.2.1 High Device Costs Associated with dPCR
5.2.2.2 Technical Limitations of qPCR and dPCR
5.2.3 Key Market Opportunities
5.2.3.1 Growing Market Penetration in Emerging Countries
5.2.3.2 Shift from Plant-Derived to Genome-Based Drug Discovery
5.2.4 Key Market Challenges
5.2.4.1 Adoption and Implementation of MIQE Guidelines
5.2.5 Key Market Trends
5.2.5.1 Development of Compact, Portable, and Lab-On-Chip PCR Devices
5.2.5.2 Ongoing Technological Integration with the PCR Process
5.3 Industry Trends Related to COVID-19
5.4 Global Regulatory Scenario
5.5 Ecosystem: Parent Market
5.6 Porter's Five Forces Analysis
5.6.1 Degree of Competition
5.6.2 Bargaining Power of Suppliers
5.6.3 Bargaining Power of Buyers
5.6.4 Threat of New Entrants
5.6.5 Threat of Substitutes
6 PCR Technologies Market, by Technique
6.1 Introduction
6.2 Conventional PCR
6.2.1 High Adoption of this Technique and Its Diverse Applications to Sustain Market Growth
6.3 Real-Time PCR
6.3.1 Growing Adoption Among Researchers and Healthcare Professionals to Fuel Market Growth
6.4 Digital PCR
6.4.1 Ongoing Technological Developments with Respect to Digital PCR to Drive Market Growth
6.5 Reverse Transcription PCR
6.5.1 Higher Sensitivity for mRNA Detection is a Major Contributing Factor to Market Growth
6.6 Hot-Start PCR
6.6.1 Hassle-Free Setup of Samples is a Key Advantage Offered by this Technique
6.7 Multiplex PCR
6.7.1 Cost-Effectiveness of this Technique to Drive Market Growth
6.8 Other PCR Techniques
7 PCR Technologies Market, by Product Type
7.1 Introduction
7.2 Instruments
7.2.1 Increasing Availability of Innovative PCR Instruments Will Drive Market Growth
7.3 Reagents and Consumables
7.3.1 Increasing Number of Analytical Procedures Among Researchers to Fuel Market Growth
7.4 Software and Services
7.4.1 Automation and Digitalization of Laboratory Processes to Fuel Adoption Among End-users
8 PCR Technologies Market, by Application
8.1 Introduction
8.2 Gene Expression Analysis
8.2.1 Gene Expression Analysis is Used in Epigenetics, SIRNA Quantification, mRNA Analysis, and Cell Line Validation
8.3 Genetic Sequencing
8.3.1 Reduced Cost of Sequencing to Drive Market Growth
8.4 Genotyping
8.4.1 SNP Genotyping Can Accelerate the Era of Personalized Medicine
8.5 Nucleic Acid Detection
8.5.1 PCR Techniques Have Wide Applications in Nucleic Acid Detection
8.6 Nucleic Acid Synthesis
8.6.1 DNA Synthesis Has Opened Avenues for Progress in Biology
8.7 Standard Validation/Verification
8.7.1 PCR Techniques are Used for Regional/Global Validation to Frame Commercial/Non-Commercial Guidelines
8.8 Diagnostic Applications
8.8.1 Diagnostic Applications Segment Accounted for the Largest Share of the Market
8.9 Environmental Applications
8.9.1 PCR is the Most Sensitive Technique to Detect Pathogens in Environmental Samples
8.10 Other Applications
9 PCR Technologies Market, by End-user
9.1 Introduction
9.2 Hospitals and Diagnostic Centers
9.2.1 High Prevalence of Target Diseases to Drive Market Growth
9.3 Healthcare Industry
9.3.1 PCR Has Wide Applications in the Healthcare Industry
9.4 Academia and Government Organizations
9.4.1 Availability of Cost-Effective and Innovative PCR Products to Drive Adoption
9.5 Pharma-Biotech Companies
9.5.1 Increasing R&D Initiatives by Pharma-Biotech Companies to Fuel the Adoption of PCR Technologies
9.6 Applied Industries
9.6.1 Increasing Environmental Regulations to Drive the Adoption of PCR Techniques
9.7 Other End-users
10 PCR Technologies Market, by Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Growing Adoption of PCR Techniques in Research & Academia to Drive Market Growth
10.2.2 Canada
10.2.2.1 Government Initiatives for Supporting Genomics Research to Drive Market Growth in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Large-Scale Outsourcing of Clinical Diagnostic Testing by Hospitals to Drive Market Growth
10.3.2 UK
10.3.2.1 Growing Focus on Genomics Research to Support Market Growth in the UK
10.3.3 France
10.3.3.1 Initiatives for Developing Genomic Medicine to Support Market Growth in France
10.3.4 Italy
10.3.4.1 Increasing R&D Investments by Pharmaceutical Companies to Propel Market Growth
10.3.5 Spain
10.3.5.1 Increasing Prevalence of Chronic and Infectious Diseases to Drive Market Growth
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.1.1 Strong Research and Healthcare Infrastructure to Support Market Growth in Japan
10.4.2 China
10.4.2.1 Healthcare Infrastructure Modernization to Support Market Growth in China
10.4.3 India
10.4.3.1 Presence of a Large Target Patient Population to Support Market Growth in India
10.4.4 Australia
10.4.4.1 High Healthcare Expenditure in the Country to Support Market Growth
10.4.5 South Korea
10.4.5.1 Growing Number of Private Hospitals and Independent Testing Laboratories to Drive Market Growth
10.4.6 Rest of Asia-Pacific
10.5 Latin America
10.5.1 Brazil
10.5.1.1 Brazil is Expected to Dominate the LATAM Market
10.5.2 Mexico
10.5.2.1 Favorable Trade Agreements Will Support Imports and Improve the Accessibility to PCR Instruments in Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 Low Purchasing Power of End-users and Infrastructural Limitations to Restrain Market Growth in the MEA
11 Competitive Landscape
11.1 Overview
11.2 Global Market Share Analysis
11.2.1 Global PCR Technologies Market Share Analysis (2019)
11.3 Competitive Leadership Mapping
11.3.1 Stars
11.3.2 Emerging Leaders
11.3.3 Pervasive
11.3.4 Participants
11.4 Competitive Scenario
12 Company Profiles
12.1 Key Players
12.1.1 Thermo Fisher Scientific, Inc.
12.1.1.1 Products & Services Offered
12.1.1.2 Recent Developments
12.1.1.3 Analyst's View
12.1.2 F. Hoffman-La Roche Ltd.
12.1.2.1 Products & Services Offered
12.1.2.2 Recent Developments
12.1.3 Bio-Rad Laboratories, Inc.
12.1.3.1 Products & Services Offered
12.1.3.2 Recent Developments
12.1.3.3 Analyst's View
12.1.4 Qiagen N.V.
12.1.4.1 Products Offered
12.1.4.2 Recent Developments
12.1.5 Takara Bio, Inc.
12.1.5.1 Products Offered
12.1.5.2 Recent Developments
12.1.6 Agilent Technologies, Inc.
12.1.6.1 Products Offered
12.1.6.2 Recent Developments
12.1.7 Biomérieux S.A.
12.1.7.1 Products Offered
12.1.7.2 Recent Developments
12.1.8 Fluidigm Corporation
12.1.8.1 Products Offered
12.1.8.2 Recent Developments
12.1.9 Danaher Corporation
12.1.9.1 Products Offered
12.1.9.2 Recent Developments
12.1.10 Abbott Laboratories
12.1.10.1 Products Offered
12.1.10.2 Recent Developments
12.2 Other Players
12.2.1 Merck KGaA
12.2.1.1 Products & Services Offered
12.2.1.2 Recent Developments
12.2.2 Becton, Dickinson and Company
12.2.2.1 Products Offered
12.2.2.2 Recent Developments
12.2.3 Promega Corporation
12.2.3.1 Products Offered
12.2.3.2 Recent Developments
12.2.4 Eppendorf AG
12.2.4.1 Products Offered
12.2.4.2 Recent Developments
12.2.5 Analytik Jena AG (A Wholly Owned Subsidiary of Endress+Hauser AG)
12.2.5.1 Products Offered
13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: The Subscription Portal
13.3 Available Customizations
List of Tables
Table 1 PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 2 Conventional PCR Market, by Region, 2018-2025 (USD Million)
Table 3 Conventional PCR Market, by Product Type, 2018-2025 (USD Million)
Table 4 Conventional PCR Market, by Application, 2018-2025 (USD Million)
Table 5 Conventional PCR Market, by End-user, 2018-2025 (USD Million)
Table 6 Real-Time PCR Market, by Region, 2018-2025 (USD Million)
Table 7 Real-Time PCR Market, by Product Type, 2018-2025 (USD Million)
Table 8 Real-Time PCR Market, by Application, 2018-2025 (USD Million)
Table 9 Real-Time PCR Market, by End-user, 2018-2025 (USD Million)
Table 10 Digital PCR Market, by Region, 2018-2025 (USD Million)
Table 11 Digital PCR Market, by Product Type, 2018-2025 (USD Million)
Table 12 Digital PCR Market, by Application, 2018-2025 (USD Million)
Table 13 Digital PCR Market, by End-user, 2018-2025 (USD Million)
Table 14 Reverse Transcription PCR Market, by Region, 2018-2025 (USD Million)
Table 15 Reverse Transcription PCR Market, by Product Type, 2018-2025 (USD Million)
Table 16 Reverse Transcription PCR Market, by Application, 2018-2025 (USD Million)
Table 17 Reverse Transcription PCR Market, by End-user, 2018-2025 (USD Million)
Table 18 Hot-Start PCR Market, by Region, 2018-2025 (USD Million)
Table 19 Hot-Start PCR Market, by Product Type, 2018-2025 (USD Million)
Table 20 Hot-Start PCR Market, by Application, 2018-2025 (USD Million)
Table 21 Hot-Start PCR Market, by End-user, 2018-2025 (USD Million)
Table 22 Multiplex PCR Market, by Region, 2018-2025 (USD Million)
Table 23 Multiplex PCR Market, by Product Type, 2018-2025 (USD Million)
Table 24 Multiplex PCR Market, by Application, 2018-2025 (USD Million)
Table 25 Multiplex PCR Market, by End-user, 2018-2025 (USD Million)
Table 26 Other PCR Techniques Market, by Region, 2018-2025 (USD Million)
Table 27 Other PCR Techniques Market, by Product Type, 2018-2025 (USD Million)
Table 28 Other PCR Techniques Market, by Application, 2018-2025 (USD Million)
Table 29 Other PCR Techniques Market, by End-user, 2018-2025 (USD Million)
Table 30 PCR Technologies Market, by Product Type, 2018-2025 (USD Million)
Table 31 PCR Instruments Market, by Region, 2018-2025 (USD Million)
Table 32 PCR Reagents and Consumables Market, by Region, 2018-2025 (USD Million)
Table 33 PCR Software and Services Market, by Region, 2018-2025 (USD Million)
Table 34 PCR Technologies Market, by Application, 2018-2025 (USD Million)
Table 35 PCR Technologies Market for Gene Expression Analysis, by Region, 2018-2025 (USD Million)
Table 36 PCR Technologies Market for Genetic Sequencing, by Region, 2018-2025 (USD Million)
Table 37 PCR Technologies Market for Genotyping, by Region, 2018-2025 (USD Million)
Table 38 PCR Technologies Market for Nucleic Acid Detection, by Region, 2018-2025 (USD Million)
Table 39 PCR Technologies Market for Nucleic Acid Synthesis, by Region, 2018-2025 (USD Million)
Table 40 PCR Technologies Market for Standard Validation/Verification, by Region, 2018-2025 (USD Million)
Table 41 PCR Technologies Market for Diagnostic Applications, by Region, 2018-2025 (USD Million)
Table 42 PCR Technologies Market for Environmental Applications, by Region, 2018-2025 (USD Million)
Table 43 PCR Technologies Market for Other Applications, by Region, 2018-2025 (USD Million)
Table 44 PCR Technologies Market, by End-user, 2018-2025 (USD Million)
Table 45 PCR Technologies Market for Hospitals and Diagnostic Centers, by Region, 2018-2025 (USD Million)
Table 46 PCR Technologies Market for Healthcare Industry, by Region, 2018-2025 (USD Million)
Table 47 PCR Technologies Market for Academia and Government Organizations, by Region, 2018-2025 (USD Million)
Table 48 PCR Technologies Market for Pharma-Biotech Companies, by Region, 2018-2025 (USD Million)
Table 49 PCR Technologies Market for Applied Industries, by Region, 2018-2025 (USD Million)
Table 50 PCR Technologies Market for Other End-users, by Region, 2018-2025 (USD Million)
Table 51 PCR Technologies Market, by Region, 2018-2025 (USD Million)
Table 52 North America: PCR Technologies Market, by Country, 2018-2025 (USD Million)
Table 53 North America: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 54 North America: PCR Technologies Market, by Product Type, 2018-2025 (USD Million)
Table 55 North America: PCR Technologies Market, by End-user, 2018-2025 (USD Million)
Table 56 US: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 57 Canada: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 58 Europe: PCR Technologies Market, by Country, 2018-2025 (USD Million)
Table 59 Europe: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 60 Europe: PCR Technologies Market, by Product Type, 2018-2025 (USD Million)
Table 61 Europe: PCR Technologies Market, by End-user, 2018-2025 (USD Million)
Table 62 Germany: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 63 UK: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 64 France: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 65 Italy: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 66 Spain: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 67 Rest of Europe: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 68 Asia-Pacific: PCR Technologies Market, by Country, 2018-2025 (USD Million)
Table 69 Asia-Pacific: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 70 Asia-Pacific: PCR Technologies Market, by Product Type, 2018-2025 (USD Million)
Table 71 Asia-Pacific: PCR Technologies Market, by End-user, 2018-2025 (USD Million)
Table 72 Japan: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 73 China: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 74 India: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 75 Australia: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 76 South Korea: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 77 Rest of Asia-Pacific: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 78 Latin America: PCR Technologies Market, by Country, 2018-2025 (USD Million)
Table 79 Latin America: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 80 Latin America: PCR Technologies Market, by Product Type, 2018-2025 (USD Million)
Table 81 Latin America: PCR Technologies Market, by End-user, 2018-2025 (USD Million)
Table 82 Brazil: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 83 Mexico: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 84 Rest of Latin America: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 85 Middle East & Africa: PCR Technologies Market, by Technique, 2018-2025 (USD Million)
Table 86 Middle East & Africa: PCR Technologies Market, by Product Type, 2018-2025 (USD Million)
Table 87 Middle East & Africa: PCR Technologies Market, by End-user, 2018-2025 (USD Million)
Table 88 PCR Technologies Market: Product Launches and Approvals, 2017-2020
Table 89 PCR Technologies Market: Expansions, 2017-2020
Table 90 PCR Technologies Market: Acquisitions, 2017-2020
Table 91 Thermo Fisher Scientific, Inc.: Business Overview
Table 92 Thermo Fisher Scientific, Inc.: Products & Services Offered
Table 93 F. Hoffman-La Roche Ltd.: Business Overview
Table 94 Exchange Rates (Utilized for Conversion of CHF to USD)
Table 95 Roche Diagnostics: Products & Services Offered
Table 96 Bio-Rad Laboratories, Inc.: Business Overview
Table 97 Bio-Rad Laboratories, Inc.: Products and Services Offered
Table 98 Qiagen N.V.: Business Overview
Table 99 Qiagen N.V.: Products Offered
Table 100 Takara Bio, Inc.: Business Overview
Table 101 Exchange Rates (Utilized for Conversion of JPY to USD)
Table 102 Takara Bio, Inc.: Products Offered
Table 103 Agilent Technologies, Inc.: Business Overview
Table 104 Agilent Technologies, Inc.: Products Offered
Table 105 Biomérieux S.A.: Business Overview
Table 106 Exchange Rates (Utilized for Conversion of EUR to USD)
Table 107 Biomérieux: Products Offered
Table 108 Fluidigm Corporation: Business Overview
Table 109 Fluidigm Corporation: Products Offered
Table 110 Danaher Corporation: Business Overview
Table 111 Danaher Corporation: Products Offered
Table 112 Abbott Laboratories: Business Overview
Table 113 Abbott Laboratories: Products Offered
Table 114 Merck KGaA: Business Overview
Table 115 Exchange Rates (Utilized for Conversion of EUR to USD)
Table 116 Merck KGaA: Products & Services Offered
Table 117 Becton, Dickinson and Company: Business Overview
Table 118 Becton, Dickinson and Company: Products Offered
Table 119 Promega Corporation: Business Overview
Table 120 Promega Corporation: Products Offered
Table 121 Eppendorf AG: Business Overview
Table 122 Exchange Rates (Utilized for the Conversion of EUR to USD)
Table 123 Eppendorf AG: Products Offered
Table 124 Endress+Hauser: Business Overview
Table 125 Exchange Rates (Utilized for Conversion of EUR to USD)
Table 126 Analytik Jena AG: Products Offered
List of Figures
Figure 1 Research Design
Figure 2 Breakdown of Primaries: PCR Technologies Market
Figure 3 Research Methodology: Hypothesis Building
Figure 4 Market Size Estimation Methodology: Global PCR Technologies Market
Figure 5 Data Triangulation
Figure 6 PCR Technologies Market, by Product Type, 2020 Vs. 2025 (USD Million)
Figure 7 PCR Technologies Market, by Technique, 2020 Vs. 2025 (USD Million)
Figure 8 PCR Technologies Market, by End-user, 2020 Vs. 2025 (USD Million)
Figure 9 APAC Market to Grow at the Highest Rate During the Forecast Period
Figure 10 Rising Incidence of Target Infectious Diseases and Genetic Disorders is Expected to Drive Market Growth
Figure 11 Real-Time PCR Segment Accounted for the Largest Share of the Global PCR Technologies Markets in 2020
Figure 12 Diagnostic Applications Segment to Dominate the Market During the Forecast Period
Figure 13 APAC Market to Register the Highest Growth Rate During the Forecast Period
Figure 14 PCR Technologies Market: Drivers, Restraints, Opportunities, and Challenges
Figure 15 Global Burden of HIV Infections, by Region, 2017
Figure 16 Growing Geriatric Population Across Key Geographies, 2019 Vs. 2050 (Million)
Figure 17 Traditional PCR Vs. qPCR and dPCR
Figure 18 North America: PCR Technologies Market Snapshot
Figure 19 Asia-Pacific: PCR Technologies Market Snapshot
Figure 20 Key Developments by Leading Players in the PCR Technologies Market, 2017-2020
Figure 21 Global PCR Technologies Market Share Analysis, by Key Player (2019)
Figure 22 PCR Technologies Market: Competitive Leadership Mapping (2019)
Figure 23 PCR Technologies Market: Competitive Leadership Mapping (SME/Start-Ups)
Figure 24 Thermo Fisher Scientific, Inc.: Company Snapshot (2019)
Figure 25 Roche Diagnostics: Company Snapshot (2019)
Figure 26 Bio-Rad Laboratories, Inc.: Company Snapshot (2019)
Figure 27 Qiagen N.V.: Company Snapshot (2019)
Figure 28 Takara Bio, Inc.: Company Snapshot (2019)
Figure 29 Agilent Technologies, Inc.: Company Snapshot (2019)
Figure 30 Biomérieux S.A.: Company Snapshot (2019)
Figure 31 Fluidigm Corporation: Company Snapshot (2019)
Figure 32 Danaher Corporation: Company Snapshot (2019)
Figure 33 Abbott Laboratories: Company Snapshot (2019)
Figure 34 Merck KGaA: Company Snapshot (2019)
Figure 35 Becton, Dickinson and Company: Company Snapshot (2019)
Figure 36 Eppendorf AG: Company Snapshot (2019)
Figure 37 Endress+Hauser AG: Company Snapshot (2019)
Executive Summary
Companies Mentioned
- Abbott Laboratories
- Agilent Technologies, Inc.
- Analytik Jena AG (A Wholly Owned Subsidiary of Endress+Hauser AG)
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Biomérieux S.A.
- Danaher Corporation
- Eppendorf AG
- F. Hoffman-La Roche Ltd.
- Fluidigm Corporation
- Merck KGaA
- Promega Corporation
- Qiagen N.V.
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | April 2021 |
| Forecast Period | 2020 - 2025 |
| Estimated Market Value ( USD | $ 7.2 Billion |
| Forecasted Market Value ( USD | $ 9.8 Billion |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
